The upregulation of ADGRL1, CDK5R1/CDKL3, CHRNB2, and ROR2 gene expression in the context of long-lasting post-stroke brain fatigue can have a mix of positive and negative effects, depending on how these proteins influence brain function, recovery, and energy regulation. This evidence concerns the gene ADGRL1 and stroke disorder.